The clinical performance is complex and often involves multi-system fatigue. Early identification and standardized diagnosis are critical to improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in bringing together a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of the treatment of PF-ILD involves the development of an individual treatment program, which typically includes pharmacotherapy, rehabilitation interventions, regular follow-up, and more. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat infectious respiratory digestive endocrine disorders have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PF-ILD-associated placebo-dependent therapy. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.